Evidence map›Paper›PMID 39875013›Full record

ArticleJournal of substance use and addiction treatment2025

Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S.

Wiley D Jenkins, Lauren B Beach, John Schneider, Samuel R Friedman, Mai T Pho, Suzan Walters, Jerel Ezell, April M Young, Caitie Hennessy, William C Miller and 18 more

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Wiley D JenkinsDepartment of Public Health Sciences, Clemson University, Clemson, SC, United States of America. Electronic address: wileyj@clemson.edu.
Lauren B BeachDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
John SchneiderBiological Sciences Division, University of Chicago, Chicago, IL, United States of America.
Samuel R FriedmanDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
Mai T PhoDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States of America.
Suzan WaltersDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
Jerel EzellDepartment of Community Health Sciences, University of California, Berkeley, Berkeley, CA, United States of America.
April M YoungDepartment of Epidemiology and Environmental Health, University of Kentucky, Lexington, KY, United States of America.
Caitie HennessySocial Statistical and Environmental Sciences, Research Triangle Institute International, Durham, NC, United States of America.
William C MillerDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Vivian F GoDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Christina SunCollege of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
David W SealTulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States of America.
Ryan P WestergaardDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America.
Heidi M CraneDepartment of Medicine, University of Washington, Seattle, WA, United States of America.
Rob J FredericksenDepartment of Medicine, University of Washington, Seattle, WA, United States of America.
Stephanie A RudermanDepartment of Medicine, University of Washington, Seattle, WA, United States of America.
Scott FletcherThe Community Action Place, Murphysboro, IL, United States of America.
Jimmy MaDepartment of Medicine, University of Washington, Seattle, WA, United States of America; General Internal Medicine, University of Washington, Seattle, WA, United States of America.
J A DelaneyDepartment of Epidemiology, Emory Rollins School of Public Health, Atlanta, GA, United States of America.
Karma PlaisanceDepartment of Epidemiology, Emory Rollins School of Public Health, Atlanta, GA, United States of America.
Judith FeinbergDepartments of Behavioral Medicine and Psychiatry & Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, United States of America.
Gordon S SmithDepartment of Epidemiology and Biostatistics, West Virginia University School of Public Health, Morgantown, WV, United States of America.
P Todd KorthuisDepartment of Medicine, Oregon Health & Sciences University, Portland, OR, United States of America.
Thomas J StopkaDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States of America.
Peter D FriedmannOffice of Research, University of Massachusetts Chan Medical School of Medicine-Baystate, Springfield, MA, United States of America.
William ZuleRTI International, Durham, NC, United States of America.
Mike WinerDepartment of Medicine, Oregon Health & Sciences University, Portland, OR, United States of America.

Funding

Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UH3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2019 to 2022
$5.2M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak InvestigationU24DA044801 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2017 to 2022
$3.3M
Community-based, client-centered prevention homes to address the rural opioid epidemicUH3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2019 to 2022
$2.6M
Learning from the COVID-19 pandemic to improve emergency management planning for harm reduction services in rural OhioUH3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2019 to 2022
$2.5M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUH3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2019 to 2021
$2.4M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUG3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2017 to 2018
$1.2M
NIDA NIH HHS U24 DA044801NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044822NIDA NIH HHS UG3 DA044823NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044829NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831NIDA NIH HHS UH3 DA044798NIDA NIH HHS UH3 DA044822NIDA NIH HHS UH3 DA044823NIDA NIH HHS UH3 DA044826NIDA NIH HHS UH3 DA044829NIDA NIH HHS UH3 DA044831
6 · The paper itself

Abstract

introductionPeople who use drugs (PWUD) are at risk of HIV infection, but the frequency and distribution of transmission-associated behaviors within rural communities is not well understood. Further, while interventions designed to more explicitly affirm individuals' sexual orientation and behaviors may be more effective, descriptions of behavior variability by orientation are lacking. We sought to describe how disease transmission behaviors and overdose risk vary by sexual orientation and activity among rural PWUD.

methodsFrom 01/2018-03/2020, rural PWUD participating in the Rural Opioid Initiative were surveyed across 8 sites. Collected data included: demographics; experiences with drug use, overdose, and healthcare; stigma; gender identity; and sexual orientation and partners. Participants were categorized as: monosexual by orientation and behavior (Mono-only), monosexual by orientation but behaviorally bisexual (Mono/Bi), and bisexual by orientation (Bi+). Analyses included descriptive summaries, bivariate examination (chi-square), and logistic regression (relative risk [RR] and 95 % confidence interval [CI]).

resultsThe 1455 participants were 84.8 % Mono-only, 3.2 % Mono/Bi, and 12.0 % Bi+. Compared to Mono-only men, Mono/Bi and Bi+ men had greater risk of transactional sex (RR = 9.71, CI = 6.66-14.2 and RR = 5.09, CI = 2.79-9.27, respectively) and sharing syringes for injection (RR = 1.58, CI = 1.06-2.35 and RR = 1.85, CI = 1.38-2.47). Compared to Mono-only women, Mono-Bi and Bi+ women had greater risk of transactional sex (RR = 4.47, CI = 2.68-7.47 and RR = 2.63, CI = 1.81-3.81); and Bi+ women had greater risk of sharing syringes for injection (RR = 1.49, CI = 1.23-1.81), sharing syringes to mix drugs (RR = 1.44, CI = 1.23-1.69), and experiencing an overdose (RR = 1.32, CI = 1.12-1.56). Bi+ men and women both more frequently reported selling sex as a source of income (versus Mono-only, both p < 0.050) and measures of perceived stigma (all p < 0.050).

conclusionsRural PWUD who are bisexual by orientation or behavior are significantly more likely to engage in behaviors associated with infectious disease transmission and to experience stigma and drug overdose. Given the growing recognition of bisexuality as a distinct orientation that warrants individualized consideration, interventions that are specifically acknowledging and affirming to the circumstances of this group are needed.

Indexed as

Drug UsersRural PopulationSexual and Gender MinoritiesSexual BehaviorSubstance-Related DisordersAdultDrug OverdoseFemaleGender IdentityHIV InfectionsHumansMaleMiddle AgedSocial StigmaUnited StatesInfectious DiseaseOverdosePeople who use drugsRural

Identifiers

PMID39875013
PMCPMC13255774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.